<DOC>
	<DOCNO>NCT02593201</DOCNO>
	<brief_summary>Peritoneal dialysis ( PD ) first-line treatment end stage renal disease ( ESRD ) Hong Kong . Despite advance antibiotic therapy connecting system , recurrent peritonitis remain major cause peritoneal failure . A recent study show elevated bacterial DNA fragment level PD effluent 5 day prior completion antibiotic predict development relapse recurrent peritonitis episode . We hypothesize prolonged antibiotic therapy PD patient peritonitis high PD effluent bacterial DNA fragment level could prevent development relapse recurrent peritonitis . We plan conduct randomize control study 360 patient PD peritonitis . After inform consent , randomize receive one additional week effective antibiotic treatment ( Preemptive Treatment Group ) additional treatment ( Control Group ) . Specimens PD effluent collect 5 day prior completion antibiotic measurement bacterial DNA fragment . All patient follow 6 month completion antibiotic therapy development relapsing , recurrent , repeat peritonitis episode . Our study determine efficacy test-before-treat algorithm could reduce incidence relapse recurrent peritonitis , time , minimize unnecessary use prolong antibiotic treatment .</brief_summary>
	<brief_title>The Efficacy Prolonged Antibiotic Therapy Prevention Relapsing Peritonitis Peritoneal Dialysis Patients With High Dialysis Effluent Bacterial DNA Fragment Levels</brief_title>
	<detailed_description />
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Cefazolin</mesh_term>
	<mesh_term>Ceftazidime</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Patients peritoneal dialysisrelated peritonitis Patients fungal peritonitis Patients obvious surgical problem require laparotomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>